Neoleukin Therapeutics, Inc.

NASDAQ:NLTX

3.49 (USD) • At close December 18, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420222021202020192018201720162015201420132012
Assets:
Current Assets:
Cash & Cash Equivalents 136.58637.887142.467192.556143.09376.92852.03232.30139.52614.90611.0062.001
Short Term Investments 175.81958.497000056.05370.75834.95624.1912.8210
Cash and Short Term Investments 312.40596.384142.467192.556143.09376.928108.085103.059112.9439.09713.8272.001
Net Receivables 00000.5030.2370.740.4260.0320.0650.0280.029
Inventory 00000000-0.03200.0640
Other Current Assets 3.5182.751.5221.966000038.7720.1391.3770.035
Total Current Assets 315.92399.134143.989194.522143.59677.165108.825103.485113.25439.30215.2962.064
Non-Current Assets:
Property, Plant & Equipment, Net 18.49315.87817.21813.7242.830.40.9050.8490.0890.1050.0750.158
Goodwill 000000000000
Intangible Assets 000.1280.3470.567000000.0630.085
Goodwill and Intangible Assets 000.1280.3470.567000000.0630.085
Long Term Investments 000000050.04638.4582.00300
Tax Assets 000000000000
Other Non-Current Assets 1.3140.9361.9281.9260.030.0530.5990-38.4580.0130.2150.035
Total Non-Current Assets 19.80716.81419.27415.9973.4270.4531.50450.8950.0892.1210.3530.278
Total Assets 335.73115.948163.263210.519147.02377.618110.329154.38113.34341.42315.6492.342
Liabilities & Equity:
Current Liabilities:
Account Payables 1.3360.4780.5261.3231.6040.7026.0166.862.2050.7340.60.189
Short Term Debt 2.9991.5151.2210.7080.618000000.250
Tax Payables 000000000000
Deferred Revenue 00000000001.7510
Other Current Liabilities 9.4869.0696.8895.8582.5213.9254.942.6592.5874.4690.0190.197
Total Current Liabilities 15.15711.0628.6367.8894.7434.62710.9569.5194.7925.2032.620.385
Non-Current Liabilities:
Long Term Debt 9.42910.55511.76311.4140.5930.0060.0330.047002.0360
Deferred Revenue Non-Current 000000000000
Deferred Tax Liabilities Non-Current 000000000000
Other Non-Current Liabilities 0.76900000.3130.4530.150.1310.0720.2353.058
Total Non-Current Liabilities 10.19810.55511.76311.4140.5930.3190.4860.1970.1310.0722.26653.058
Total Liabilities 25.35521.61720.39919.3035.3364.94611.4429.7164.9235.2764.88753.443
Equity:
Preferred Stock 000000000000
Common Stock 000000000000.535
Retained Earnings -262.298-451.055-393.498-332.806-299.529-230.087-198.502-148.278-111.276-89.416-63.631-51.636
Accumulated Other Comprehensive Income/Loss 0-0.021000-0.443-0.07-0.169-0.29-0.004-0.253-0.395
Other Total Stockholders Equity 572.673545.407536.362524.022441.216303.202297.459293.111219.986125.56774.6460.395
Total Shareholders Equity 310.37594.331142.864191.216141.68772.67298.887144.664108.4236.14710.763-51.101
Total Equity 094.331142.864191.216141.68772.672000000
Total Liabilities & Shareholders Equity 335.73115.948163.263210.519147.02377.618110.329154.38113.34341.42315.6492.342